IDXX Idexx Laboratories Inc

Price (delayed)

$475.63

Market cap

$39.28B

P/E Ratio

45.6

Dividend/share

N/A

EPS

$10.43

Enterprise value

$39.93B

IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and ...

Highlights
The company's equity has surged by 87% YoY and by 6% QoQ
The quick ratio has soared by 83% YoY

Key stats

What are the main financial stats of IDXX
Market
Shares outstanding
82.59M
Market cap
$39.28B
Enterprise value
$39.93B
Valuations
Price to book (P/B)
25.19
Price to sales (P/S)
10.61
EV/EBIT
35.49
EV/EBITDA
32.16
EV/Sales
10.72
Earnings
Revenue
$3.72B
EBIT
$1.13B
EBITDA
$1.24B
Free cash flow
$796.79M
Per share
EPS
$10.43
Free cash flow per share
$9.59
Book value per share
$18.88
Revenue per share
$44.83
TBVPS
$34.05
Balance sheet
Total assets
$3.35B
Total liabilities
$1.78B
Debt
$1.05B
Equity
$1.57B
Working capital
$545.07M
Liquidity
Debt to equity
0.67
Current ratio
1.57
Quick ratio
0.95
Net debt/EBITDA
0.53
Margins
EBITDA margin
33.3%
Gross margin
60.1%
Net margin
23.3%
Operating margin
30%
Efficiency
Return on assets
27.6%
Return on equity
63.7%
Return on invested capital
45.2%
Return on capital employed
47%
Return on sales
30.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IDXX stock price

How has the Idexx Laboratories stock price performed over time
Intraday
0.91%
1 week
1.04%
1 month
-3.15%
1 year
-14.56%
YTD
-14.31%
QTD
-2.37%

Financial performance

How have Idexx Laboratories's revenue and profit performed over time
Revenue
$3.72B
Gross profit
$2.24B
Operating income
$1.12B
Net income
$866.57M
Gross margin
60.1%
Net margin
23.3%
The company's net income rose by 24% YoY and by 2.5% QoQ
IDXX's operating income is up by 20% YoY
The net margin has grown by 14% YoY
IDXX's operating margin is up by 11% YoY

Growth

What is Idexx Laboratories's growth rate over time

Valuation

What is Idexx Laboratories stock price valuation
P/E
45.6
P/B
25.19
P/S
10.61
EV/EBIT
35.49
EV/EBITDA
32.16
EV/Sales
10.72
The company's EPS rose by 24% YoY and by 2.6% QoQ
IDXX's price to earnings (P/E) is 22% lower than its 5-year quarterly average of 57.9 and 11% lower than its last 4 quarters average of 50.8
The company's equity has surged by 87% YoY and by 6% QoQ
The price to book (P/B) is 66% less than the 5-year quarterly average of 73.0 and 21% less than the last 4 quarters average of 31.4
The P/S is 15% below the 5-year quarterly average of 12.3 and 10% below the last 4 quarters average of 11.7
IDXX's revenue is up by 9% year-on-year

Efficiency

How efficient is Idexx Laboratories business performance
Idexx Laboratories's return on equity has decreased by 46% YoY and by 11% QoQ
Idexx Laboratories's return on invested capital has increased by 16% YoY
The company's return on sales rose by 11% YoY
The return on assets rose by 7% year-on-year

Dividends

What is IDXX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IDXX.

Financial health

How did Idexx Laboratories financials performed over time
The company's total assets is 88% higher than its total liabilities
The quick ratio has soared by 83% YoY
IDXX's current ratio is up by 45% year-on-year
The debt is 33% less than the equity
The company's equity has surged by 87% YoY and by 6% QoQ
IDXX's debt to equity has shrunk by 57% YoY and by 6% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.